Clinical Trial Update: Single Ascending Dose Study With Healthy Male Volunteers and Type II Diabetic Patients [Phase 1]

View source ↗

Summary

A Phase 1 single ascending dose study in healthy male volunteers and Type 2 diabetes mellitus patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 1 | Status: TERMINATED